Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion.
Shack S, Chen LC, Miller AC, Danesi R, Samid D. Shack S, et al. Among authors: samid d. Int J Cancer. 1995 Sep 27;63(1):124-9. doi: 10.1002/ijc.2910630122. Int J Cancer. 1995. PMID: 7558439
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.
DiGiuseppe JA, Weng LJ, Yu KH, Fu S, Kastan MB, Samid D, Gore SD. DiGiuseppe JA, et al. Among authors: samid d. Leukemia. 1999 Aug;13(8):1243-53. doi: 10.1038/sj.leu.2401471. Leukemia. 1999. PMID: 10450753 Free article.
Cinnamic acid: a natural product with potential use in cancer intervention.
Liu L, Hudgins WR, Shack S, Yin MQ, Samid D. Liu L, et al. Among authors: samid d. Int J Cancer. 1995 Jul 28;62(3):345-50. doi: 10.1002/ijc.2910620319. Int J Cancer. 1995. PMID: 7628877
Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate.
Stockhammer G, Manley GT, Johnson R, Rosenblum MK, Samid D, Lieberman FS. Stockhammer G, et al. Among authors: samid d. J Neurosurg. 1995 Oct;83(4):672-81. doi: 10.3171/jns.1995.83.4.0672. J Neurosurg. 1995. PMID: 7674018
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer.
Thibault A, Figg WD, Bergan RC, Lush RM, Myers CE, Tompkins A, Reed E, Samid D. Thibault A, et al. Among authors: samid d. Tumori. 1998 Jan-Feb;84(1):87-9. Tumori. 1998. PMID: 9619724 Clinical Trial.
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Samid D, Shack S, Myers CE. Samid D, et al. J Clin Invest. 1993 May;91(5):2288-95. doi: 10.1172/JCI116457. J Clin Invest. 1993. PMID: 8486788 Free PMC article.
Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.
Liu L, Shack S, Stetler-Stevenson WG, Hudgins WR, Samid D. Liu L, et al. Among authors: samid d. J Invest Dermatol. 1994 Sep;103(3):335-40. doi: 10.1111/1523-1747.ep12394874. J Invest Dermatol. 1994. PMID: 8077698
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrate.
Figg WD, Walls RG, Cooper MR, Thibault A, Sartor O, McCall NA, Myers CE, Samid D. Figg WD, et al. Among authors: samid d. Anticancer Drugs. 1994 Jun;5(3):336-42. doi: 10.1097/00001813-199406000-00012. Anticancer Drugs. 1994. PMID: 7919459
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.
Liu L, Hudgins WR, Miller AC, Chen LC, Samid D. Liu L, et al. Among authors: samid d. Cytokine. 1995 Jul;7(5):449-56. doi: 10.1006/cyto.1995.0061. Cytokine. 1995. PMID: 7578983
Cytostatic activity of phenylacetate and derivatives against tumor cells. Correlation with lipophilicity and inhibition of protein prenylation.
Hudgins WR, Shack S, Myers CE, Samid D. Hudgins WR, et al. Among authors: samid d. Biochem Pharmacol. 1995 Oct 12;50(8):1273-9. doi: 10.1016/0006-2952(95)02013-3. Biochem Pharmacol. 1995. PMID: 7488244
69 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page